Crossover Bioequivalence Study of Quetiapine Fumarate 300 mg Tablets Under Steady State Fasted Conditions

Clinical trial NCT01570959 · COMPLETED

Trial details

NCT number: NCT01570959
Sponsor: Roxane Laboratories
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Bipolar I Disorder

Start date: 2007-04-01
Primary completion: 2007-11-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.